Observing safety and effectiveness of Zepzelca for lung cancer
Part of Cancer clinical trials.
This study tracks how safe and effective the drug Zepzelca (a chemotherapy) is for people with advanced small cell lung cancer that has not responded to earlier platinum-based chemo. It allows patients to receive the drug as part of their normal care while researchers collect data.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of lung cancer called small cell lung cancer (SCLC) that has spread.
- You have already tried platinum-based chemo (like cisplatin or carboplatin) and it did not work anymore.
- You are scheduled to receive or have already received the study drug Zepzelca.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You are not taking part in any other clinical trial right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called ZL-1310, alone or with other treatments, for people with small cell lung cancer that has spread (extensive-stage). It aims to see if ZL-1310 can help shrink tumors or slow the disease.
This trial tests a new drug, ZL-1310, against standard treatments for people with small cell lung cancer that has returned after initial therapy. The goal is to see if ZL-1310 works better than other options.
This trial tests a new study medicine, PF-08634404, combined with chemotherapy for people with extensive-stage small cell lung cancer. It aims to see if this combination works better than standard treatments.
This study tests a new drug (GSK5764227) for people whose extensive-stage small cell lung cancer has gotten worse after platinum chemotherapy combined with immunotherapy. The goal is to see if this targeted treatment can help shrink tumors and control the cancer.
This Phase 1 trial tests whether blocking an enzyme (with an acetazolamide-like medicine) can be safely combined with standard treatment for small cell lung cancer that has not spread. The goal is to see if the treatment can be given safely and to learn early signs of benefit.
This trial tests different treatments based on the genetic and molecular features of your tumor. It is for people with stage IV small cell lung cancer that has returned after initial chemotherapy.
Hear when a new SCLC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.